Laboratorios Farmaceuticos Rovi S.../ ES0157261019 /
07/03/2024 14:38:47 | Chg. - | Volume | Bid29/02/2024 | Demandez à04/12/2023 | Haut | Bas |
---|---|---|---|---|---|---|
78.55EUR | - | 139 Chiffrre d'affaires: 10,918.45 |
-Bid taille: - | -Ask la taille: - | 78.55 | 78.55 |
GlobeNewswire
08:14
STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire
08:00
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire
07:30
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
07:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
07:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
07:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
07:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
07:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
06:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
05:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page